|
Risk Factors
Citations 31-35 of 35 total displayed.
|
Past content
(since Oct 2008):
|
- Advances in Genetics, Proteomics, and Metabolomics
Progressing From Risk Factors to Omics
- Peter W.F. Wilson
Circ Cardiovasc Genet 2008;1:141-146, doi:10.1161/CIRCGENETICS.108.815605
[Full text]
- Methods in Genetics and Clinical Interpretation
Determination of Paraoxonase 1 Status Without the Use of Toxic Organophosphate Substrates
- Rebecca J. Richter, Gail P. Jarvik, and Clement E. Furlong
Circ Cardiovasc Genet 2008;1:147-152, doi:10.1161/CIRCGENETICS.108.811638
[Full text]
- Original Article
Interactions of Functional APOE Promoter Polymorphisms with Smoking on Aortic Atherosclerosis
- Leena E. Viiri, Keijo M. Viiri, Erkki Ilveskoski, Heini Huhtala, Markku Mäki, Pentti J. Tienari, Markus Perola, Terho Lehtimäki, and Pekka J. Karhunen
Circ Cardiovasc Genet published October 15, 2008, doi:10.1161/CIRCGENETICS.108.791764
[Abstract]
- Original Article
Association of Variation in the Chromosome 9p21 Locus with Myocardial Infarction versus Chronic Coronary Artery Disease
- Benjamin D. Horne, John F. Carlquist, Joseph B. Muhlestein, Tami L. Bair, and Jeffrey L. Anderson
Circ Cardiovasc Genet published October 15, 2008, doi:10.1161/CIRCGENETICS.108.793158
[Abstract]
- Advances in Genetics, Proteomics, and Metabolomics
Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era
- Christopher J. O'Donnell and Elizabeth G. Nabel
Circ Cardiovasc Genet 2008;1:51-57, doi:10.1161/CIRCGENETICS.108.813337
[Full text]
|
|
